BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
CPA Canada appoints eight directors as new governance model takes effect - 2Treasure trove found in Egyptian tomb solves ancient mystery
- 3How to disinfect if the stomach bug hits your home
- 4Explainer-Why are hepatitis B vaccines given to newborns?
- 5NASA releases stunning first images of Earth taken by the Artemis II astronauts
- Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities
- Lilly, Novo lock horns in India's obesity drug race
- Israel approves death penalty law for Palestinians convicted of attacks
- 20-year-old who threatened German train attack remanded in custody
- Air Canada CEO To Resign After Backlash—Here’s Why Communication Skills Is Now A Leadership Requirement
- Ifo: Job cuts in Germany slowing but not enough for a turnaround
- McDonald's is bringing two 'KPop Demon Hunters' meals to McDonald's. Here's what they include and when they launch.
- RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
- Make your choice for a definitive Christmas getaway destination!
